文献速递心血管CT

冠状动脉疾病与高敏心肌肌钙蛋白的关系:基于冠状动脉CT血管成像和人工智能斑块定量的评估

Relation of Coronary Artery Disease and High-Sensitivity Cardiac Troponin: Evaluation with CCTA and AI-enabled Plaque Quantification.
PubMed 文献 · Radiol Cardiothorac Imaging · 2025-01-01

这项单中心回顾性队列研究纳入527例急诊胸痛患者,按峰值高敏心肌肌钙蛋白T水平分为不可测组、中间组和升高组,均行冠状动脉CT血管成像,对冠状动脉疾病报告与数据系统评分大于0者用人工智能工具定量斑块。中位随访29个月发生22例主要不良心血管事件,升高的肌钙蛋白水平与主要不良心血管事件风险增加无关,而总斑块体积大于250 mm³是主要不良心血管事件和全因死亡的显著预测因子。

要点

  • 总斑块体积大于250 mm³是主要不良心血管事件(HR 2.62)和全因死亡(HR 3.62)的显著预测因子。
  • 升高的高敏心肌肌钙蛋白T水平与主要不良心血管事件风险增加无关。
  • 总、钙化、非钙化及低密度非钙化斑块体积随肌钙蛋白水平升高而显著增加(P < .001)。

核心结论

  • 在该队列中,人工智能定量的总斑块体积可预测主要不良心血管事件,而肌钙蛋白水平不能。

研究设计与样本

  • 单中心回顾性队列研究,纳入2016年2月至2021年3月因急性症状就诊急诊并接受高敏心肌肌钙蛋白T检测的患者527例,均行冠状动脉CT血管成像,冠状动脉疾病报告与数据系统评分大于0者用基于人工智能的斑块工具定量斑块。

关键影像表现/征象

  • 总、钙化、非钙化及低密度非钙化斑块体积随肌钙蛋白水平升高而显著增加(P < .001)。
  • 冠状动脉CT血管成像示冠状动脉疾病总体患病率为59%,高敏心肌肌钙蛋白T未升高患者中为55%。

诊断标准与关键数值

  • 按峰值高敏心肌肌钙蛋白T水平分组:不可测组小于5 ng/L(141例)、中间组5-13 ng/L(275例)、升高组大于或等于14 ng/L(111例)。
  • 总斑块体积大于250 mm³预测主要不良心血管事件:HR 2.62(95% CI:1.13,6.07),P = .02。
  • 总斑块体积大于250 mm³预测全因死亡:HR 3.62(95% CI:1.25,10.50),P = .02。

临床应用与阅片要点

  • 作者认为本研究支持在真实世界人群中使用冠状动脉CT血管成像联合人工智能斑块定量进行风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the relationship between artificial intelligence (AI)-quantified coronary plaque characteristics derived from coronary CT angiography (CCTA), stenosis severity, and high-sensitivity cardiac troponin T (hs-cTnT) levels in predicting adverse cardiovascular outcomes in emergency department patients. Materials and Methods This single-center retrospective cohort study included patients who presented acutely to the emergency department and underwent hs-cTnT testing (February 2016-March 2021). Based on peak hs-cTnT levels, patients were categorized into three groups: undetectable (<5 ng/L), intermediate (5-13 ng/L), and elevated (≥14 ng/L). All patients underwent CCTA, and those with Coronary Artery Disease Reporting and Data System score > 0 underwent plaque quantification using an AI-based plaque tool. Patients were followed up for major adverse cardiovascular events (MACE), including acute coronary syndrome, stroke, all-cause mortality, and late revascularization. Statistical analysis included nonparametric tests, χ2 tests, and Cox hazards regression. Results Among 527 patients (291 [55%] male; mean age, 56 years ± 12 [SD]), 141 had undetectable, 275 had intermediate, and 111 had elevated hs-cTnT levels. Coronary artery disease prevalence at CCTA was 59% overall and 55% in patients with nonelevated hs-cTnT levels. Total, calcified, noncalcified, and low-density noncalcified plaque volumes increased significantly with higher troponin levels (P < .001). Over a median 29-month follow-up period, 22 MACE occurred. Elevated hs-cTnT level was not associated with increased MACE risk, whereas total plaque volume > 250 mm3 was a significant predictor of both MACE (hazard ratio [HR], 2.62 [95% CI: 1.13, 6.07]; P = .02) and all-cause mortality (HR, 3.62 [95% CI: 1.25, 10.50]; P = .02). Conclusion In this cohort, AI-quantified total plaque volume predicted MACE whereas troponin level did not. This study supports the use of CCTA with AI-based plaque quantification for risk stratification in a real-world population. Keywords: CT Angiography, Coronary Arteries, Arteriosclerosis, Coronary Artery Disease, Plaque Quantification, Troponin, Coronary Computed Tomography Angiography, Artificial Intelligence Supplemental material is available for this article. © RSNA, 2025.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Ferkh A, Khoo JK, Hasific S, et al. Relation of Coronary Artery Disease and High-Sensitivity Cardiac Troponin: Evaluation with CCTA and AI-enabled Plaque Quantification. Radiol Cardiothorac Imaging. 2025. PMID: 41065551. doi:10.1148/ryct.250002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。